Advertisement
To participate in the live teleconference, please call (877) 604-9672, or(719) 325-4896 for international callers, fifteen minutes before theconference begins. Live audio of the call will be simultaneously broadcastover the Internet and will be available to members of the news media,investors and the general public. Access to live and archived audio of theconference call will be available on the Investor Relations section athttp://www.monogrambio.com. Following the live broadcast, a replay of the callwill also be available at (888) 203-1112 or (719) 457-0820 for internationalcallers, through Sunday, November 9, 2008. The replay passcode is 4461917.The information provided on the teleconference is only accurate at the time ofthe conference call, and Monogram will take no responsibility for providingupdated information except as required by law.
Advertisement
About Monogram Biosciences, Inc.
Monogram is advancing individualized medicine by discovering, developingand marketing innovative products to guide and improve treatment of seriousinfectious diseases and cancer. The Company's products are designed to helpdoctors optimize treatment regimens for their patients that lead to betteroutcomes and reduced costs. The Company's technology is also being used bynumerous biopharmaceutical companies to develop new and improved anti-viraltherapeutics and vaccines as well as targeted cancer therapeutics. Moreinformation about the Company and its technology can be found on its web siteat www.monogrambio.com.
Trofile is a trademark of Monogram Biosciences, Inc. Selzentry is atrademark of Pfizer Inc.contacts: Alfred G. Merriweather Jeremiah Hall Chief Financial Officer Feinstein Kean Healthcare Tel: 650 624-4576 Tel: 415 677-2700 [email protected] [email protected]
SOURCE Monogram Biosciences, Inc.
